Changes in plasma HIV-1 virus load during mobilization and harvesting of stem cells for individual subjects.

(A) Cohort 1. (B) Cohort 2. (C) Cohort 3. (vertical dotted lines) Granulocyte colony-stimulating factor was administered on days 1 through 7. (arrows) Leukapheresis was performed on days 4 and 5. For subject 620 745 in cohort 1, a day-27 plasma sample was unavailable. Levels of plasma HIV-1 RNA for subjects 610 020 and 620 736 were below the limit of detection and are not shown.